LOS ANGELES, CALIFORNIA — October 29, 2025 — Leads & Copy — eXoZymes Inc. (NASDAQ:EXOZ) CEO Michael Heltzen will present at the Spartan Capital Securities Investor Conference on November 3 in New York City.
eXoZymes has developed a biomanufacturing platform capable of producing valuable natural products using AI-optimized enzymes. Heltzen said its product, NCT, targets a combined $100 billion global market for metabolic diseases and gut health.
Heltzen will present at 11:20 AM on Monday, November 3, at Track 4 of the Marriott Marquis Hotel. The conference will showcase over 60 companies and expects 500+ investors.
Spartan Capital Securities CEO John D. Lowry, and B2i Digital CEO David Shapiro also commented on the upcoming event.
Lasse Görlitz, VP of Communications
(858) 319-7135
press@exozymes.com
Source: eXoZymes Inc.
